Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-dependent analgesic efficacy and local tolerability of diclofenac oromucosal spray in sore throat
2015-003947-21Phase 2Completed
- Sponsor
- Farmaka
- Start
- Nov 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of diclofenac in pharyngitis (3 arms), sponsored by Farmaka. Primary endpoint: Primary analgesic efficacy. Started Nov 2015; status: completed.
02
Drugs
diclofenac
03
Conditions
pharyngitis
Beyond the preview
Go deeper on 2015-003947-21.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003947-21.